Primary |
Hypercholesterolaemia |
20.9% |
Hypertension |
13.9% |
Hyperlipidaemia |
12.3% |
Dyslipidaemia |
8.6% |
Pruritus |
5.3% |
Blood Cholesterol Increased |
4.8% |
Coronary Artery Disease |
4.3% |
Diabetes Mellitus |
4.3% |
Cerebrovascular Spasm |
3.2% |
Osteoporosis Postmenopausal |
3.2% |
Type 2 Diabetes Mellitus |
2.7% |
Abdominal Pain Upper |
2.1% |
Cardiovascular Disorder |
2.1% |
Lipids Abnormal |
2.1% |
Myalgia |
2.1% |
Heart Transplant |
1.6% |
Hepatitis C |
1.6% |
Nasopharyngitis |
1.6% |
Rash |
1.6% |
Renal Failure |
1.6% |
|
Myalgia |
24.7% |
Rhabdomyolysis |
9.9% |
Liver Disorder |
8.6% |
Vomiting |
7.4% |
Rash |
6.2% |
Cardiac Arrest |
3.7% |
Oesophageal Hypomotility |
3.7% |
Thrombotic Thrombocytopenic Purpura |
3.7% |
Uveitis |
3.7% |
White Blood Cell Count Decreased |
3.7% |
Blood Creatine Phosphokinase Increased |
2.5% |
Cardiac Failure |
2.5% |
Cerebellar Haematoma |
2.5% |
Muscle Spasms |
2.5% |
Musculoskeletal Stiffness |
2.5% |
Neutrophil Count Decreased |
2.5% |
Oedema |
2.5% |
Pain In Extremity |
2.5% |
Photocoagulation |
2.5% |
Pyrexia |
2.5% |
|
Secondary |
Hyperlipidaemia |
17.7% |
Product Used For Unknown Indication |
15.1% |
Hypertension |
12.8% |
Hypercholesterolaemia |
10.0% |
Drug Use For Unknown Indication |
9.4% |
Type 2 Diabetes Mellitus |
5.3% |
Prophylaxis |
4.0% |
Glomerulonephritis |
3.7% |
Blood Cholesterol Increased |
2.9% |
Type Iib Hyperlipidaemia |
2.6% |
Diabetes Mellitus |
2.2% |
Dyslipidaemia |
2.1% |
Immune Thrombocytopenic Purpura |
2.1% |
Thrombotic Cerebral Infarction |
2.0% |
Bipolar Disorder |
1.6% |
Type Iia Hyperlipidaemia |
1.6% |
Nephrotic Syndrome |
1.3% |
Osteoarthritis |
1.3% |
Coronary Artery Disease |
1.2% |
Osteoporosis Prophylaxis |
1.1% |
|
Vomiting |
18.1% |
Amyotrophic Lateral Sclerosis |
13.0% |
Rash |
10.9% |
Pyrexia |
6.5% |
Talipes |
6.5% |
Rhabdomyolysis |
5.8% |
Musculoskeletal Discomfort |
4.3% |
Myalgia |
4.3% |
Vision Blurred |
4.3% |
Myopathy |
2.9% |
Transaminases Increased |
2.9% |
Vascular Graft |
2.9% |
Completed Suicide |
2.2% |
Drug Tolerance |
2.2% |
Hepatic Function Abnormal |
2.2% |
Hepatocellular Injury |
2.2% |
Interstitial Lung Disease |
2.2% |
Lung Disorder |
2.2% |
Nephropathy Toxic |
2.2% |
Polyneuropathy |
2.2% |
|
Concomitant |
Product Used For Unknown Indication |
22.0% |
Hypertension |
15.9% |
Drug Use For Unknown Indication |
11.0% |
Renal Transplant |
6.2% |
Prophylaxis Against Transplant Rejection |
4.7% |
Diabetes Mellitus |
3.9% |
Type 2 Diabetes Mellitus |
3.6% |
Acute Myocardial Infarction |
3.5% |
Prophylaxis |
3.4% |
Hyperlipidaemia |
3.3% |
Multiple Myeloma |
2.8% |
Atrial Fibrillation |
2.8% |
Hypercholesterolaemia |
2.5% |
Immunosuppression |
2.4% |
Pain |
2.2% |
Osteoporosis |
2.1% |
Rheumatoid Arthritis |
2.1% |
Depression |
2.1% |
Insomnia |
1.7% |
Non-small Cell Lung Cancer |
1.7% |
|
Renal Failure Acute |
9.8% |
Pyrexia |
8.1% |
Syncope |
7.7% |
Vomiting |
7.3% |
Pneumonia |
6.4% |
Pain In Extremity |
5.6% |
Weight Decreased |
5.6% |
Urinary Tract Infection |
5.1% |
Myocardial Infarction |
4.7% |
Pancreatitis Acute |
4.7% |
Cerebrovascular Accident |
4.3% |
Nausea |
4.3% |
Sepsis |
4.3% |
Hepatic Function Abnormal |
3.8% |
Hyponatraemia |
3.8% |
Atrial Fibrillation |
3.0% |
Death |
3.0% |
Transplant Rejection |
3.0% |
Tremor |
3.0% |
Cardiac Failure |
2.6% |
|
Interacting |
Hypertension |
20.0% |
Bipolar I Disorder |
10.0% |
Age-related Macular Degeneration |
6.7% |
Heart Transplant |
6.7% |
Lipids Increased |
6.7% |
Prophylaxis |
6.7% |
Acidosis |
3.3% |
Anaemia |
3.3% |
Cardiac Failure |
3.3% |
Drug Use For Unknown Indication |
3.3% |
Dyslipidaemia |
3.3% |
Helicobacter Gastritis |
3.3% |
Hiccups |
3.3% |
Hypercholesterolaemia |
3.3% |
Hyperlipidaemia |
3.3% |
Hyperparathyroidism Secondary |
3.3% |
Hyperuricaemia |
3.3% |
Immunosuppressant Drug Therapy |
3.3% |
Renal Transplant |
3.3% |
|
Visual Acuity Reduced |
22.2% |
White Blood Cell Count Increased |
22.2% |
Blood Creatine Phosphokinase Increased |
11.1% |
Renal Failure Chronic |
11.1% |
Rhabdomyolysis |
11.1% |
Tachypnoea |
11.1% |
Vomiting |
11.1% |
|